Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.
about
Clinical significance of microRNAs in chronic and acute human leukemiaMicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma.miR-539 inhibits prostate cancer progression by directly targeting SPAG5Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemiaClinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression.Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.MicroRNAs as prognostic biomarker and relapse indicator in leukemia.Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia SurvivalExpression of the miR-148/152 Family in Acute Myeloid Leukemia and its Clinical Significance.The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer
P2860
Q26749533-E156428C-64C4-4C63-ACBC-55ED83A4E47BQ33685185-3E17FCF3-E9CD-49D2-9A85-9A38B9E9AC4AQ36350011-7BD2480D-870B-4BB7-8233-F320FF121A21Q36758507-E8C29289-670B-4D90-BD62-B956847DA26AQ37288474-9BA0777C-16B3-45CE-A64D-4024D074CA6EQ37327466-9FB7DB8A-AB4A-4880-8BA6-0490A4E8FD82Q38452459-4148B815-16D8-47ED-888D-A684EF0FB088Q38660295-3D82C9E4-B376-413B-BE5F-E9B92BC926ACQ39167466-1D5E1D23-D3F5-4349-AC5D-0708026FA5FBQ42267035-1551C8DA-FAB6-402F-BA8C-1CC991F0850CQ42376720-B1F91181-C164-4808-B395-90EC30050FCCQ47149216-B0D6FB04-86BF-4633-9A29-A6051F121C0AQ49173154-663E5477-C39D-4381-8D7E-A0FC8C482C3FQ51058964-ADA1E439-A9EC-4C89-BBF6-3B8BC9BD1051Q51542696-703A380F-769E-4FA2-B1E3-1595C2775A4CQ59128537-BF320660-C37B-4C15-9F70-2CA0E69C3D52
P2860
Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low expression of microRNA-204 ...... eloid leukemia (AML) patients.
@ast
Low expression of microRNA-204 ...... eloid leukemia (AML) patients.
@en
type
label
Low expression of microRNA-204 ...... eloid leukemia (AML) patients.
@ast
Low expression of microRNA-204 ...... eloid leukemia (AML) patients.
@en
prefLabel
Low expression of microRNA-204 ...... eloid leukemia (AML) patients.
@ast
Low expression of microRNA-204 ...... eloid leukemia (AML) patients.
@en
P2093
P2860
P1476
Low expression of microRNA-204 ...... yeloid leukemia (AML) patients
@en
P2093
Aleksandra Butrym
Andrzej Tukiendorf
Dagmara Baczyńska
Justyna Rybka
Kazimierz Kuliczkowski
P2860
P2888
P356
10.1186/S13046-015-0184-Z
P50
P577
2015-07-01T00:00:00Z
P5875
P6179
1019467467